The Wegovy pill: oral semaglutide for weight loss, explained

Wegovy semaglutide by Novo Nordisk

By the GLP Index editorial team Updated How we source

The Wegovy pill is a once-daily 25 mg oral semaglutide — the first GLP-1 pill approved for weight loss. Here's how it works, how it compares to the shot, and how to get it.

What is the Wegovy pill?

The Wegovy pill is a once-daily tablet of oral semaglutide — the same molecule as the Wegovy pen, in a swallowable form approved for chronic weight management. It’s the first GLP-1 pill to carry a weight-loss label, and it exists for one simple reason: a lot of people who would benefit from semaglutide don’t want a weekly injection.

The dose is the headline detail. Because only a tiny fraction of a swallowed peptide survives digestion, the pill is dosed much higher than the injection — 25 mg daily — to deliver a comparable effect.

How well does the oral version work?

In its trial program, the 25 mg pill produced weight loss roughly in line with the weekly pen — meaningful double-digit percentages of body weight over the better part of a year. The practical read: the two are close enough on results that the choice comes down to which format you’ll actually stick with.

Two caveats carry over from the mechanism. Results build over months, not weeks, and — like every drug in this class — they last as long as treatment does. Stop, and appetite and most of the weight return.

The Wegovy pill vs the injection

Wegovy pillWegovy pen
FormDaily tabletWeekly injection
Dose25 mg oralUp to 2.4 mg subcutaneous
RoutineEmpty stomach, 30-min waitAny time, with or without food
Track recordNewYears of real-world data
NeedlesNoneYes

Neither is “better” across the board. The pen is simpler day-to-day (once a week, no food rules) and better-proven; the pill wins for anyone who won’t inject.

Dosing and how to take it

The administration rules are the same strict routine that governs all oral semaglutide: take it first thing in the morning on an empty stomach, with no more than about 4 oz of plain water, then wait roughly 30 minutes before eating, drinking anything else, or taking other medications. Miss that window and absorption drops.

Like the injection, the pill is titrated up over time to let your gut adjust and to limit nausea, rather than started at the full 25 mg.

How to get the Wegovy pill

It’s prescription-only, through the same routes as the pen — your own doctor or a telehealth provider — and subject to the same coverage reality: insurers that balk at semaglutide for weight loss will balk at the pill too. If cost is the obstacle, our Wegovy cost guide walks through savings options, and the broader cheapest-GLP-1 rundown compares every route. For the full drug picture, see the complete Wegovy guide.

FAQ

Common questions about Wegovy pill

Is the Wegovy pill as effective as the injection?

In trials, the 25 mg oral dose landed roughly comparable to the weekly pen — close enough that the honest answer is whichever one you'll take consistently. The pen has years more real-world data; the pill removes needles entirely.

How do you take the Wegovy pill?

On an empty stomach, first thing in the morning, with no more than about 4 oz of plain water — then wait roughly 30 minutes before eating, drinking anything else, or taking other medications. The routine is strict because so little of a swallowed peptide is absorbed.

Is the Wegovy pill the same as Rybelsus?

Same molecule, different product. Both are oral semaglutide, but Rybelsus is approved for type 2 diabetes at doses up to 14 mg, while the Wegovy pill is a higher 25 mg dose approved for weight management. They are not interchangeable.

How much does the Wegovy pill cost?

Pricing is still settling out, but expect it to sit in the same range as the pen before insurance — often around four figures a month at list. Coverage for weight loss remains the deciding variable, same as the injection.

Sources

Every claim on this page traces to primary literature or FDA labeling. Browse the full evidence library.

  1. Wegovy prescribing information (FDA label) (Novo Nordisk / FDA)
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) (New England Journal of Medicine, 2021)
This page is for informational purposes only and isn't medical advice. Talk to a licensed healthcare provider about your situation before starting, stopping, or changing any medication. See our medical disclaimer and editorial policy.

Written by the GLP Index editorial team · Updated July 23, 2026 · How we source